Skip to main content
. 2021 Aug 24;10(17):3777. doi: 10.3390/jcm10173777

Table 3.

Allele and genotype distribution for the NOD2 c.2722G>C (p.G908R, rs2066845) variant.

c.2722G>C (p.G908R)
rs2066845
Genotypes
n (%)
Alleles
n (%)
Group n CC GC GG C G
IBD whole group 578 1 (0.2%) 41 (7.1%) 536 (92.7%) 43 (3.7%) 1113 (96.3%)
UC adults 211 n.o. 16 (7.6%) 195 (92.4%) 16 (3.8%) 406 (96.2%)
UC adult women 99 n.o. 7 (7.1%) 92 (92.9%) 7 (3.5%) 191 (96.5%)
UC adult man 112 n.o. 9 (8.1%) 103 (91.9%) 9 (4%) 215 (96%)
UC children 65 n.o. 1 (1.5%) 64 (98.5%) 1 (0.8%) 129 (99.2%)
UC girls * 28 n.o. n.o. 28 (100%) 0 (0%) 56 (100%)
UC boys 37 n.o. 1 (2.7%) 36 (97.3%) 1 (1.3%) 73 (98.7%)
UC whole group 276 n.o. 17 (6.2%) 259 (93.8%) 17 (3.1%) 535 (96.9%)
CD adults 217 1 (0.5%) 14 (6.5%) 202 (93%) 16 (3.7%) 418 (96.3%)
CD adult women 117 1 (0.9%) 10 (8.5%) 106 (90.6%) 12 (5.1%) 222 (94.9%)
CD adult men 100 n.o. 4 (4%) 96 (%) 4(2%) 196 (98%)
CD children 85 n.o. 10 (11.8%) 75 (88.2%) 10 (5.9%) 160 (94.1%)
CD girls 41 n.o. 3 (7.3%) 38 (92.7%) 3 (3.7%) 79 (96.3%)
CD boys 44 n.o. 7 (15.9%) 37 (84.1%) 7 (7.9%) 81 (92.1%)
CD whole group 302 1 (0.4%) 24 (7.9%) 277 (91.7%) 26 (4.3%) 578 (95.7%)
Controls 715 n.o. 15 (2.1%) 700 (97.9%). 15 (1.1%) 1415 (98.9%)
(CC) vs. (GG)
OR
95% CI
p-value
(GC) vs. (GG)
OR
95% CI
p-value
(CC) + (GC) vs. (GG)
OR
95% CI
p-value
(C) vs. (G)
OR
95% CI
p-value
IBD vs. controls OR = 3.49
CI = (0.14–85.92)
p = 0.280
OR = 1.09
CI = (0.04–28.30)
p = 0.551
OR = 3.34
CI = (0.13–82.02)
p = 0.291
OR = 3.34
CI = (1.85–6.02)
p < 0.001
UC adults vs. controls n.a. OR = 0.89
CI = (0.02–47.36)
p = 1.000
OR = 3.37
CI = (0.07–170.19)
p = 1.000
OR = 3.94
CI = (1.95–7.96)
p < 0.001
UC children vs. controls n.a. OR = 10.33
CI = (0.14–734.03)
p = 1.000
OR = 10.92
CI = (0.21–555.02)
p = 1.000
OR = 0.73
CI = (0.09–5.58)
p = 1.000
UC adults vs. UC children n.a. OR = 0.08
CI = (0.00–6.06)
p = 1.000
OR = 0.31
CI = (0.00–15.69)
p = 1.000
OR = 5.38
CI = (0.71–40.88)
p = 0.089
UC women vs. UC men n.a. OR = 1.27
CI = (0.02–71.63)
p = 1.000
OR = 1.13
CI = (0.02–57.51)
p = 1.000
OR = 0.87
CI = (0.32–2.39)
p = 0.795
UC girls vs. UC boys n.a. OR = 3.00
CI = (0.02–473.06)
p = 1.000
OR = 1.32
CI = (0.02–68.34)
p = 1.000
OR = 0.43
CI = (0.01–10.85)
p = 1.203
UC whole group vs. controls OR = 2.16
CI = (0.04–109.03)
p = 1.000
OR = 0.83
CI = (0.02–44.73)
p = 1.000
OR = 2.09
CI = (0.04–105.50)
p = 1.000
OR = 2.55
CI = (1.27–5.09)
p = 0.006
CD adults vs. controls OR = 10.38
CI = (0.42–255.72)
p = 0.063
OR = 3.21
CI = (0.12–85.20)
p = 0.309
OR = 9.91
CI = (0.40–244.26)
p = 0.069
OR = 3.61
CI = (1.77–7.36)
p < 0.001
CD children vs. controls n.a. OR = 1.47
CI = (0.02–80.39)
p = 1.000
OR = 8.37
CI = (0.16–424.45)
p = 1.000
OR = 5.89
CI = (2.60–13.34)
p < 0.001
CD adults vs. CD children OR = 1.12
CI = (0.04–27.76)
p = 0.542
OR = 2.17
CI = (0.08–58.76)
p = 0.405
OR = 1.18
CI = (0.05–29.37)
p = 0.530
OR = 0.61
CI = (0.27–1.38)
p = 0.232
CD women vs. CD men OR = 2.71
CI = (0.11–67.52)
p = 0.342
OR = 1.28
CI = (0.04–37.98)
p = 0.532
OR = 2.58
CI = (0.10–64.24)
p = 0.354
OR = 2.65
CI = (0.85–8.35)
p = 0.085
CD girls vs. CD boys n.a. OR = 2.14
CI = (0.03–131.93)
p = 1.000
OR = 1.07
CI = (0.02–55.28)
p = 1.000
OR = 0.44
CI = (0.11–1.76)
p = 0.332
CD whole group vs. controls OR = 7.57
CI = (0.31–186.46)
p = 0.112
OR = 1.89
CI = (0.07–49.60)
p = 0.433
OR = 7.11
CI = (0.29–175.26)
p = 0.124
OR = 4.24
CI = (2.23–8.07)
p < 0.001
CD whole group vs. UC whole group OR = 3.50
CI = (0.14–86.46)
p = 0.279
OR = 2.26
CI = (0.08–58.83)
p = 0.390
OR = 3.40
CI = (0.14–83.97)
p = 0.287
OR = 1.66
CI = (0.90–3.06)
p = 0.099

Statistically significant results are marked in bold; n.o.: not observed; n.a.: not analyzed (CC genotype was not detected in both juxtaposed groups); *: deviation from HWE.